Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-FR Version v3-FR
Language French French
Date Updated 2019-10-04 2019-10-04
Drug Identification Number 02392852 02392852
Brand name RAN-PREGABALIN RAN-PREGABALIN
Common or Proper name RAN-PREGABALIN RAN-PREGABALIN
Company Name RANBAXY PHARMACEUTICALS CANADA INC. RANBAXY PHARMACEUTICALS CANADA INC.
Ingredients PREGABALIN PREGABALIN
Strength(s) 225MG 225MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 500 500
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-09-27 2019-09-27
Remaining supply date 2019-09-27 2019-09-27
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments Discontinuation of 500 size only. 100's remain available. Discontinuation of 500 size only. 100's remain available.
Health Canada comments